A Third Actos Generic to Begin Posing Cancer Risk

10/25/2012 13:05:27 PM

A federal judge has said a third company can begin selling Actos generics immediately – even after the Food and Drug Administration (FDA) said otherwise. Watson Pharmaceuticals was initially denied the approval to sell the …

Consumer Reports: Avoid Actos — and its Generics — At All Costs

10/05/2012 11:30:50 AM

Even after the FDA approved generic versions of Actos in August, a nonprofit consumer watchdog group said you should “skip” them. The FDA approved pioglitazone hydrochloride tablets to treat type 2 diabetes this summer, despite …

Canadians Taking a Stand Against Actos

09/12/2012 18:47:18 PM

Jimmy Whyte, a Canadian man, petitioned for a class action lawsuit against Takeda Pharmaceuticals and Eli Lilly & Co., the manufacturers and distributors of Actos. Whyte had been taking Actos for type 2 diabetes starting …

Miracle Drug or Risky Business?

09/07/2012 11:11:47 AM

Alzheimer’s is a disease that affects the memory, thinking and actions of an individual. Scientists have studied the disease and have found that the disease involves progressive brain cell failure, but the reason why is …

Actos Gets the Maple Leaf Stamp of Disapproval

07/27/2012 15:37:32 PM

The United States’ “neighbors to the north” are among the growing number of countries from which extensive research has emerged linking bladder cancer to Actos.

Blind Eye to Risks: Actos Linked to Vision Problems

06/13/2012 18:37:04 PM

Amidst the nationwide filing of Actos bladder cancer lawsuits, the rumors that Actos is linked to an increased likelihood of heart attack like Avandia, and the latest study that reveals Actos-induced vision problems, we are …

Plot Thickens in Dangerous Diabetes Drugs Scandal

06/01/2012 12:05:29 PM

A Takeda researcher who is fired after raising concerns about the integrity of her company’s safety reports. A well-respected cardiologist with questionable industry ties. A damning medical study that destroys the profits for one drug … ...

Actos Manufacturer Strikes Out Again

05/04/2012 18:33:08 PM

Takeda Pharmaceuticals, maker of Actos, tried to slip one past the Food and Drug Administration (FDA) again, but this time the Agency isn’t having it. Last week, the FDA denied approval for alogliptin, a drug …

New Bladder Cancer Treatment Saves Woman’s Life

05/01/2012 10:59:38 AM

Wendy Powell was just 36 years old when she was diagnosed with life-threatening bladder cancer. The diagnosis was made after doctors discovered a tumor that was roughly the size of a lemon in the British …

Doctor Calls for Prosecution of Dishonest Pharma Companies

04/21/2012 09:50:51 AM

How is it that pharmaceutical companies are able to market drugs even after they are aware of dangerous and potentially life-threatening side effects? What is wrong with our consumer protection system that allows these companies …